Worldwide, 850 million people are affected by chronic kidney disease (CKD)—a worrying figure, and one that continues to rise. Treatment options for patients with CKD are multiple and often determined by the etiology of ...
Aug 31, 2020
0
7
Medication for high blood pressure could improve COVID-19 survival rates and reduce the severity of infection—according to new research from the University of East Anglia.
Aug 24, 2020
1
50
A large-scale analysis of the clinical characteristics of Alport syndrome in Japanese patients has revealed that the effectiveness of existing treatment with ACE inhibitors and/or angiotensin receptor blockers (RAS inhibitors) ...
Aug 7, 2020
0
2
(HealthDay)—More than one-third of stroke survivors have uncontrolled hypertension, and about one in five are not taking antihypertensive medications, according to a study published online July 27 in JAMA Neurology.
Aug 3, 2020
0
6
A new Northwestern Medicine study in mice found a widely used class of drugs to treat patients with hypertension, cardiovascular disease and diabetic kidney disease—many of whom are elderly—does not increase the risk ...
Jul 22, 2020
0
0
Patients with raised blood pressure have a two-fold increased risk of dying from the coronavirus COVID-19 compared to patients without high blood pressure, according to new research published in the European Heart Journal ...
Jun 5, 2020
0
7
A Yale-led study suggests that older COVID-19 patients taking ACE inhibitors for hypertension have a lower risk of hospitalization for the novel coronavirus.
May 28, 2020
0
22
In the search for treatments for COVID-19, many researchers are focusing their attention on a specific protein that allows the virus to infect human cells. Called the angiotensin-converting enzyme 2, or ACE2 "receptor," the ...
May 14, 2020
1
6
Evidence from a large study of several thousand patients shows that men have higher concentrations of angiotensin-converting enzyme 2 (ACE2) in their blood than women. Since ACE2 enables the coronavirus to infect healthy ...
May 11, 2020
0
600
(HealthDay)—Angiotensin-converting enzyme inhibitor (ACEI) and/or angiotensin receptor blocker (ARB) use is not associated with COVID-19 test positivity, according to a study published online May 5 in JAMA Cardiology.
May 8, 2020
0
2
